How long has jardiance been on market?

When did Jardiance (empagliflozin) first launch?

Jardiance (empagliflozin) was approved by the FDA in August 2014 and launched soon after in the U.S., meaning it has been on the market for roughly about 11 years as of mid-2025.

How many years is that, exactly?

Using the FDA approval timeframe (August 2014) as the starting point, Jardiance has been on market for:
- ~10 years by August 2024
- ~11 years by August 2025

Where can I verify the timeline and filings?

For patent and exclusivity-related market timing (including key filings and patent status), DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/p/jardiance/

What “on the market” can mean (approval vs. wider rollout)

The exact “on market” number can vary depending on whether you mean:
- FDA approval date (when it became available for prescribing in the U.S.)
- Launch/availability date (when it was actually stocked and sold broadly)
- First approval in other countries (Europe and elsewhere may differ)

If you tell me which country you mean (U.S., EU, etc.), I can pin the duration to that specific market.

Sources:
[1] https://www.drugpatentwatch.com/p/jardiance/